🆕Team design as innovation in perioperative care: the case of HPB anesthesiology
➡️https://buff.ly/U5wd2VX
"Change takes time – in all fields, including surgery... But not all improvements require new technology."
@halletjulie.bsky.social #surgery #team #HPB #medsky #surgsky
Posts by Julie Hallet, MD MSc
. @nanets.bsky.social @enets.org @ascocancer.bsky.social
💥Bone mets in SI-NETs – more common than you think!
🦴25% on PET-CT
😌14% pain, 4% fracture
⏳Stage IV pts with 🦴 mets ⬇️ median survival vs without
📊>5 lesions has ⬇️ survival
What's the best strategy for bone treatments in #NETs? 💭
ow.ly/GB2N50WCokB
#NETSky #OncSky #MedSky #SurgSky
. @nanets.bsky.social @socsurgonc.bsky.social
💭Guess what day it is? #NETs OR 🦓 with Dr Meloche-Dumas
She’s focusing on NETs during surg onc fellowship. The NETs field needs more dedicated surgeons like her - watch out for what’s to come!
So fun to create tailored multidisciplinary NETs rotations with UofT SurgOnc
#NETsky #SurgSky #MedSky
Mesoappendix invasion not a criteria for right hemi in appendix NETs
👥4800 pts
🔬meso invasion not associated with LN+ on its own
📏size main risk factor
No difference in OS appendectomy vs right hemi👌
Timely for @nanets.bsky.social guidelines!
link.springer.com/article/10.1...
#NETSky #SurgSky
#HPBSky Also check out the great ergonomics in surgery primer from last year 📑 🔑 at @bjsacademy.bsky.social 👏🏻 @halletjulie.bsky.social
🆕 Ergonomics in the OR is a safety imperative
The OR looks choreographed—yet beneath it lie serious ergonomic hazards for the surgical team.
Read more on BJS Academy ⬇️
buff.ly/7QuQvlA
@halletjulie.bsky.social @bjsurgery.bsky.social #surgsky #medsky #surgery
OR under pressure⚡️
Live observations 👀 👉🏻multiple ergonomic hazards across types of surgeries
‼️poor layouts
🤸awkward postures
🏃trip risks
📟tech fails
Involving all team members😷
Time to make OR safe for workers!
📝🔗 academic.oup.com/bjs/article-...
#SurgSky #MedSky
. @nanets.bsky.social @enets.org @socsurgonc.bsky.social @essonews.bsky.social @ihpba.bsky.social @stefanopartelli.bsky.social
Defining high-risk pancreas #NETs
496 resections 🇮🇹🇫🇷🇨🇦
Early recurrence
71% if venous thrombosis
41% if Ki 67>5% + tumor >3cm + ⬆️LN
⚠️Signs of biologically borderline-resectable NETs
🛑 before resection ➡️ start with systemic💊
🔗 journals.lww.com/annalsofsurg...
#NETSky #HPBSky #PancSky #SurgSky
🎙️New data for management of #HCC
What is new?
What is in the works?
Review this & more with Adam
Yopp, Amit Singhal & Katie Kelley in new #SurgOncToday podcast 🎧 from @socsurgonc.bsky.social
A real masterclass in perioperative care for HCC 🔝
#HPBsky #SurgSky #medsky #oncsky
What will my life look like after surgery?
The STAYHOME tool can help with this question for older adults for cancer surgery:
🏡 individualized risk of staying home at 6 & 12 months
😷 uses preop info
✅ good discrimination & well calibrated
📝 in JAMASurgery lnkd.in/gTtRgj_e
#SurgSky #OncSky
That was the last OR day with Dr Acher! Always bittersweet to see fellows go 🥹
So proud of the highly skilled, brilliant, whip-smart surgeon she is 🌟 @wiscsurgery.bsky.social, you're lucky to have her!
Now, we can always dream of getting her on social media 🙃
@uoftsurgery.bsky.social
Should we chase margins intraop for PDAC?
✅Yes - R0 is key for cure
❌No - R1 reflects biology, not technical cure
Great summary & sharp debate on surgical cure vs disease reality from #SSO2024 in @annsurgoncology.bsky.social between Alice Wei & David Kooby
link.springer.com/article/10.1...
Sub-typing to select NAT in #PDAC?
NeoPancONE 🇨🇦 #ASCO25 @ascocancer.bsky.social
👥84 resectable PDAC
💉mFOLFIRINOX NAT
Median OS 34 months😀
🔬Classical vs basal sub-type main predictor EFS & OS
What next 🤔: sub-type all PDAC prior to chemo? wait for more data?
ascopubs.org/doi/10.1200/...
Not in Chicago but getting the updates - #ASCO25 learnings today:
😀there's an option in BRAFV600 mCRC
😀Ipi+Nivo better in MSI-h unresectable mCRC
🫤ctDNA+ still not guiding care in CC
😳CRS+HIPEC no better with chemo
@oncbrothers.bsky.social
got the details 👉🏻 tinyurl.com/bd75xjw7
#OncSky #MedSky
Stable OR teams contribute to better outcomes🤝✨
Each additional case done by same anesthesiologist-surgeon team 👉 ⬇️ major morbidity
🔓‼ Opportunity is knocking: ⬆️outcomes by re-organizing teams
How do we do it?
🆕📝 tinyurl.com/yx44pm96
#SurgSky #MedSky #HPBSky
PRRT before surgery in #NETs? ☢️🦓
Maybe? 💭
Think about why, how to measure success, potential risks 🤔
Some key reasons to consider the approach by Jess Maxwell @mdanderson.bsky.social 👇🏻
@nanets.bsky.social
#NETsky #HPBSky #SurgSky
@enets.bsky.social @socsurgonc.bsky.social
#NETs in LA ⭐️🎥🌴
Reminder to debulk NETs liver metastases by Alexandra Gangi 🤩 @cedarssinai.bsky.social
➡️ mortality in NETs happens in the liver - treat it
⛔️ No to anatomic resection! 👉🏻 enucleate!
#NETsky #HPBSky #SurgSky #OncSky
@nanets.bsky.social
Perioperative management essentials for carcinoid syndrome
🎞️👀 sneak peek of 🗺️ international expert consensus recommendations at @essonews.bsky.social #NETs webinar today
🔹Assess for 🖤disease
🔹Identify & treat crisis fast
🔹Don't rely on octreotide!
Thanks for the invite!
#NETSky #HPBSky #SurgSky
New favourite slide from @drcnclarke.bsky.social on surgery for #PNETs 🟢🟠🔴
at AHPBA monthly fellows rounds
@nanets.bsky.social @enets.bsky.social @socsurgonc.bsky.social #NETSky #HPBSky #PancSky #SurgSky
. @nanets.bsky.social @oncothor.bsky.social @pamelakunzmd.bsky.social @heloisasoares.bsky.social @drcnclarke.bsky.social
Symptoms & QoL are key in #NETs care
New tools🧰 from @ascocancer.bsky.social for symtpom management in well-diff GEP-NETs
☑️carcinoid syndrome, heart disease, crisis & functional PNETs
☑️surgery, liver-directed therapy & systemic
🔗📝https://ascopubs.org/doi/10.1200/OP-25-00133
#NETSky #OncSky
@nanets.bsky.social @enets.bsky.social @oncothor.bsky.social @heloisasoares.bsky.social @ja
Want to know more about surgery & functioning NETs?🤨
Join @essonews.bsky.social on May 14!
🔥Will include preview of international expert consensus recommendations for periop management of carcinoid crisis🦓🌎
Register 👇🏻👇🏻
#NETSky #SurgSky #OncSky #HPBSky
Are current wait time targets optimal?
Strong work by Adom Bondzi-Simpson #AmerSurg25:
wait time & survival in #CRC
🚫 diff OS if surgery <28d (traditional target)
⬆️OS if surgery <45d (new)
Time to reconsider wait times to optimize cancer outcome vs resources? ⚖️🤔
📸cred @swexner.bsky.social